(Q34228796)

31 July 2017

1 reference

title

Expanded role for ARBs in cardiovascular and renal disease? Recent observations have far-reaching implications (English)

1 reference

31 July 2017

T M Ramahi

1

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 April 2001

1 reference

31 July 2017

published in

Postgraduate Medicine

1 reference

31 July 2017

volume

109

1 reference

31 July 2017

issue

4

1 reference

31 July 2017

page(s)

115-22; quiz 9

1 reference

Angiotensin II receptor antagonists

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2001.04.911

AT1-receptor blockers in hypertension and heart failure: clinical experience and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2001.04.911

Angiotensin receptors and their antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2001.04.911

The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2001.04.911

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2001.04.911

Angiotensin II receptor blockers: review of the binding characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2001.04.911

Losartan potassium: a review of its pharmacology, clinical efficacy and tolerability in the management of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2001.04.911

Irbesartan. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in the management of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2001.04.911

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2001.04.911

Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2001.04.911

Pharmacology of valsartan, an angiotensin II receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2001.04.911

Angiotensin II antagonists for hypertension: are there differences in efficacy?

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2001.04.911

21 January 2018

Identifiers

DOI

10.3810/PGM.2001.04.911

1 reference

31 July 2017

1 reference